-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D3Y9M28PoRVPCbYXFre9TsFGIu3c8/D3ySuQBmDwGN1cLhpakfi7zoZql0hDeHMy MPnd/PAUxtNU9T9ygU9IeA== 0000930413-11-000528.txt : 20110128 0000930413-11-000528.hdr.sgml : 20110128 20110128185057 ACCESSION NUMBER: 0000930413-11-000528 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110117 FILED AS OF DATE: 20110128 DATE AS OF CHANGE: 20110128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: del Campo Ralph CENTRAL INDEX KEY: 0001323683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 11557190 MAIL ADDRESS: STREET 1: C/O ENZON PHARMACEUTICALS INC. STREET 2: RTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER NAME: FORMER CONFORMED NAME: delcampo ralph DATE OF NAME CHANGE: 20050413 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c64179_4.xml X0303 4 2011-01-17 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001323683 del Campo Ralph C/O ENZON PHARMACEUTICALS INC. RTE 202/206 BRIDGEWATER NJ 08807 0 1 0 0 COO and Princ. Exec. Officer Common Stock 2011-01-17 5 J 0 E 18333 A 171216.136 D Common Stock 2011-01-17 4 F 0 6802 12.15 D 164414.136 D Common Stock 2011-01-27 5 J 0 E 12665 A 164414.136 D Common Stock 2011-01-27 4 F 0 4744 11.63 D 159670.136 D Shares acquired upon vesting of restricted stock granted to the Reporting Person on January 17, 2008 and reported on a Form 4 filed on January 18, 2008. The Reporting Person previously reported all restricted stock granted to the Reporting Person on January 17, 2008 in Table I of the Form 4 filed on January 18, 2008. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event. Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock described in this Form 4. Shares acquired upon vesting of restricted stock units granted to the Reporting Person on January 27, 2010 and reported on a Form 4 filed on January 29, 2010. The Reporting Person previously reported all restricted stock units granted to the Reporting Person on January 27, 2010 in Table I of the Form 4 filed on January 29, 2010. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event. Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4. /s/ Andrew Rackear, Attorney-In-Fact 2011-01-28 -----END PRIVACY-ENHANCED MESSAGE-----